Open access peer-reviewed chapter

Proteins in Calcium Phosphates Biomineralization

Written By

Marta Kalka, Anna Zoglowek, Andrzej Ożyhar and Piotr Dobryczycki

Submitted: 17 January 2019 Reviewed: 07 May 2019 Published: 06 June 2019

DOI: 10.5772/intechopen.86718

From the Edited Volume

Contemporary Topics about Phosphorus in Biology and Materials

Edited by David G. Churchill, Maja Dutour Sikirić, Božana Čolović and Helga Füredi Milhofer

Chapter metrics overview

1,235 Chapter Downloads

View Full Metrics


Biomineralization is a process of creating crystalline structures under biological control. The process takes place in hard tissues, such as bones, cartilages, and teeth. Biominerals are a combination of a crystal phase deposited onto an organic matrix. Inorganic components are mainly responsible for the biomineral hardness, while the organic matrix controls the shape, size, and polymorph of the crystals. Within the organic matrix, proteins exhibit a special biomineralization activity. Among them, one can distinguish insoluble collagen and soluble noncollagenous proteins. It is particularly noteworthy that noncollagenous proteins are intrinsically disordered proteins. High flexibility, acidic nature, and susceptibility to modifications make them especially adapted to the biomineralization control. This review paper is dedicated to the proteins which are involved in biomineralization of bones and teeth.


  • biomineralization
  • bones
  • teeth
  • intrinsically disordered proteins
  • collagen

1. Introduction

Biomineralization is a process of formation of an inorganic solid within the biological system [1]. Biominerals are organic-inorganic composites, which fulfill various biological functions. In vertebrates, hard tissues provide body support, take part in tearing food, protect organs, and are reservoirs of calcium and phosphate. Understanding of molecular basis of biomineralization is essential to obtain new biomaterials.

Human hard tissues are formed of calcium orthophosphates [2]. Among them, most important are amorphous calcium phosphate, octacalcium phosphate, calcium hydrogenphosphate dihydrate, and calcium-deficient apatite and hydroxyapatite (HA) [3]. In organisms, calcium orthophosphates occur mainly in the form of poorly crystallized nonstoichiometric sodium-, magnesium-, and carbonate-containing HA—so-called biological apatite [2, 3, 4, 5].

Biomineralization is a multistep process, which requires using the structures of extracellular matrix vesicles, numerous enzymes and glycoproteins. Due to strict control, biominerals differ from pure chemical minerals [6]. In contrast to geological minerals, biominerals are composite materials comprised of both inorganic and bioorganic components. The mineral constituent gives tissues hardness and resistance to mechanical damage. Stiffness of the tissue depends on the amount of inorganic components and organic phase [7]. About 70% of bone tissue is made up of mineral structure, while the rest is water and organic substances [1]. Moreover, having formed in vivo under well-controlled conditions, biomineral phases often have properties, such as shape, size, crystallinity, isotopic, and trace element compositions, quite unlike their inorganically formed counterparts [2].

The key factors, which determine the size, shape, internal structure and properties of biominerals, are proteins, which control the nucleation and growth of the crystals. Biomineralization involves protein-protein interactions and interactions between proteins and inorganic fraction. Among them, two major groups can be distinguished. Scaffold for a growing mineral phase provides insoluble collagen. In human bones, collagen makes up to 20–30% wt. Nucleation and crystal growth regulation are controlled by soluble, noncollagenous proteins. They are usually highly acidic [8, 9], undergo extensive posttranslational modifications [10], and frequently belong to the group of intrinsically disordered proteins (IDPs) [11]. IDPs are dynamic, flexible, heterogeneous populations of molecules without a well-defined folded structure. The highly charged character, along with the low content of hydrophobic amino acid residues, results in strong electrostatic repulsion and the lack of a well-packed hydrophobic core [12]. High content of IDPs’ carboxyl and phosphate acidic groups involved in biomineralization results in high calcium binding capabilities. Examples of proteins engaged in bones and teeth biomineralization are shown in Table 1.

Protein nameAccession numberpIMass (kDa)Overall percent disordered—PONDR
Bone sialoproteinAAA60549.14.1~3559%
Matrix extracellular phosphoglycoproteinAAK70343.18.6~5864%
Dentin matrix protein-1AAC51332.14.0~5690%
Dentin sialophosphoprotein (preproprotein)NP_055023.23.6~13188%

Table 1.

Proteins involved in bone and teeth biomineralization.

Bioinformatic predictions of a disordered structure in proteins were done with PONDR predictor ( [13].


2. The basic division of proteins involved in the formation of calcium phosphate biominerals

Bone and teeth biomineralization takes place within the extracellular matrix (ECM), outside the cells. ECM is a highly organized and complex structure, unique to the specific organ type. It is an organic, noncellular fraction of mineralized tissues, composed of structural and functional proteins [14]. The content of the organic fraction varies depending on the type of tissue and constitutes 30% of bone, 20–25% of dentin, and only 0.5% of mature enamel. The basic division of proteins involved in the formation of calcium phosphate biominerals includes insoluble matrix like collagen and soluble noncollagenous proteins (NCPs).

2.1 Collagenous proteins of ECM

Among organic phase components, there are insoluble substances, which include structural macromolecules, creating a scaffold for the growing mineral. They give shape to the resulting crystal and can act as initiators for the creation of crystallization roots. An example of such substance is collagen. Animal tissues primarily contain collagen type I or collagen type II [15]. Collagen is the major ECM molecule that self-assembles into cross-striated fibrils, provides support for cell growth, and is responsible for the mechanical resilience of connective tissues. The term “collagen” defines a whole family of glycoproteins. The most common motifs in the amino acid sequence of collagen are repeating sequence [Gly-X-Y]n, both with and without interruptions. The X and Y positions are occupied by proline and its hydroxylated form, hydroxyproline, respectively. The right-handed triple helix is formed from three left-handed polyproline α-chains of identical length, which gives collagen a unique quaternary structure [16]. Hydroxylation of the rest of the proline in collagen is necessary for the stabilization of the triple helix [17]. Collagen chains create interactions leading to the organization of chains in a four-stage array [18]. Collagen fibers are also cross-linked via lysyl residues [19]. Electron microscopy techniques allow to observe successive regions of overlap and gaps, resulting from the mutual arrangement of collagen fibers [20].

2.2 Noncollagenous proteins (NCPs) of extracellular matrix (ECM)

While structural collagen is the main protein of ECM, NCPs are important for the regulation of biomineralization. NCPs are usually acidic, capable of binding large amounts of calcium ions. Proteins, which directly influence biomineralization, act as nucleators and regulators of crystal growth and orientation [21]. NCPs are frequently posttranslationally modified, e.g., phosphorylated, glycosylated, or proteolytically processed. A large number of noncollagenous proteins have disordered secondary and tertiary structures and belong to a group of intrinsically disordered proteins [11].


3. Intrinsically disordered proteins in calcium phosphate biomineralization

IDPs are a group of proteins that have gained a special interest of researchers for over 20 years [12, 22, 23]. Their discovery was especially challenging for traditional protein structure paradigm, stating that protein function depends on a fixed tertiary structure. The IDP group includes proteins with altered secondary and tertiary structures from total random coil structure to some intrinsically disordered regions. They are characterized by considerable plasticity, flexibility, and high conformational dynamics. IDP features are high net charge and low hydrophobicity, which is not conducive to the formation of the hydrophobic core. They often bind low molecular ligands and macromolecules such as ions and proteins. By interacting with ligands, IDPs can undergo local or global structuring. They can also fulfill their functions while remaining completely disordered. Other characteristics of this group are multiple amino acid repeats and susceptibility to posttranslational modifications. An open structure and lack of a packed core increase the availability of potential phosphorylation, glycosylation, and proteolytic cleavage sites [24].

Extended, flexible structure, highly acidic nature, susceptibility to modifications and especially the ability to interact with many different partners make these proteins particularly adapted to the biomineralization control. Many NCPs belong to IDP group. Family of small integrin-binding ligand N-linked glycoprotein (SIBLING) is the example of IDPs engaged in HA formation and is presented below. In addition to SIBLINGs, enamel matrix proteins such as ameloblastin, amelotin, and enamelin also have disordered structures [25]. More information about the proteins involved in HA biomineralization belonging to IDPs can be found in reviews [11, 25, 26].


An example of NCPs is the family of small integrin-binding ligand N-linked glycoprotein (SIBLING). It is a group of proteins identified in bone, dentine, and cementum, which includes osteopontin (OPN), bone sialoprotein (BSP), dentin matrix protein-1 (DMP1), dentin sialophosphoprotein (DSPP), and matrix extracellular phosphoglycoprotein (MEPE) [27]. It is believed that they all evolved as a result of gene duplication from extracellular calcium-binding phosphoprotein family. Although proteins differ in composition of amino-acid sequence, SIBLINGs share common features [28]. Their genes are located in a 375 kb region on the 4q21 human and 5q mouse chromosomes. They display a similar exon structure. Their sequence contains an Arg-Gly-Asp (RGD) motif, which mediates cell attachment/signaling by binding to cell-surface integrins [28]. SIBLINGs belong to IDP group and are highly acidic. They share numerous sequence repeats, which are often observed in the case of IDPs [26]. Particularly important for their biomineralization activity may be acidic serine- and aspartate-rich motifs (ASARM), which are involved in the phosphate administration [29, 30]. SILBINGs are frequently posttranslationally medicated. Some of their biological functions depend on phosphorylation, glycosylation, proteolytic processing, sulfonation, or transglutaminase cross linking [31].

3.1.1 Osteopontin

Osteopontin (OPN), also known as secreted phosphoprotein 1 (SSP1), is a highly phosphorylated and glycosylated sialoprotein. It is a multifunctional protein expressed by several cell types including osteoblasts, osteocytes, as well as osteoclasts or odontoblasts [32]. OPN undergoes many posttranslational modifications such as phosphorylation, glycosylation, sulfonation, or proteolytic processing, and modifications vary depending on a protein role and localization [31]. In bones and dentin, osteopontin is located at the site of biomineral formation. Synthesis of OPN is stimulated by calcitriol, physiologically active form of vitamin D, which is known as a trigger for bone destruction and remodeling [33, 34].

Osteopontin was originally identified as a bridge between the cell and HA in ECM of bone [35]. It is known that OPN increases the adhesion of bone cells by concentrating in mineralized collagen matrix during bone formation and remodeling [36, 37]. The protein is highly produced by developing osteoblasts and osteoclasts, and it has been shown to regulate both cell type adhesions.

Another role of ONP during biomineralization is modulation of osteoclastic function. OPN binding to integrin αvβ3 is essential for regulation of osteoclastic activity and is necessary in the formation of a sealing zone [34]. Through CD44-associated cell signaling, OPN stimulates osteoclast migration [38].

As a highly acidic phosphoprotein, OPN binds to the surface of hydroxyapatite crystals through the electrostatic interactions between crystals and carboxyl and phosphate groups. Furthermore, disordered structure of OPN can promote the binding of calcium ions. The results of in vitro and in vivo studies suggest that osteopontin has an inhibitory effect on HA formation and growth [39, 40]. OPN knockout mice display increased mineral content and size [41]. Therefore, it is suggested that OPN is one of the proteins whose role is to prevent crystal formation in soft tissues. Peptides of OPN obtained after proteolytic processing differ in a biomineralization effect. ASARM peptide of OPN binds to HA crystals and consequently inhibits ECM matrix mineralization [42]. Its inhibition activity is dependent on serine residues’ phosphorylation. N- and C-terminal fragments of OPN from milk promote de novo HA formation, but at the same time, the central fragment showed an inhibitory effect [43].

3.1.2 Bone sialoprotein

Bone sialoprotein (BSP) is one of the most abundant NCPs of bone. In contrast to OPN, BSP is only localized in tissues that undergo mineralization: bone, dentin and mineralizing cartilage, and cementum [44]. The protein is produced by osteoblasts, osteocytes, osteoclasts, as well as by chondrocytes. Disordered structure of BSP was shown by NMR, CD, and SAXS studies [28, 45, 46, 47]. BSP is highly glycosylated especially at C-terminal fragment, and to a lesser extent also phosphorylated and sulfonated [31]. N-terminal region of the protein contains collagen-binding motif. In vivo and in vitro studies indicated that BSP can be involved in initial stages of hydroxyapatite biomineralization [48]. BSP is intensely expressed by osteoblastic cells in sites of primary bone formation. The protein is present at mineralizing boundaries of bone, dentin, and calcifying cartilage tissues. On the other hand, BSP increases osteoclastogenesis, and in that way, it can initiate bone remodeling. BSP knockout mice are characterized by short, hypomineralized bones with high trabecular bone mass [49, 50]. Overexpression of BSP leads to dwarfism, decreased bone mineral density, and decreased trabecular bone volume [51].

It was shown that BSP has high affinity to hydroxyapatite and acts as a de novo nucleator of HA crystals in vitro [52]. The protein also binds to type I collagen, and by interaction with collagen, BSP could regulate HA nucleation [53]. Moreover, control of mineral formation is highly associated with the state of phosphorylation, sulfonation, and glycosylation of BSP [27, 54, 55].

When creating skull bones, including the mandible, alveoli, and skull vault, the osteoprogenitor cells secrete a collagen extracellular matrix—osteoid. Skull bones are formed by intracerebral ossification. BSP affects biomineralization of the matrix in the ossification process, hence, the formation, shaping, and growth of hydroxyapatite crystals. In the absence of BSP, bone formation is delayed and osteoblast activity is impaired [56].

3.1.3 Matrix extracellular phosphoglycoprotein

Matrix extracellular phosphoglycoprotein (MEPE) is located in mineralized tissues as bone and dentin, but was found also in nonmineralized organs. The protein is primarily expressed by osteoblasts and osteocytes that are embedded within the mineralized matrix in bone and by odontoblasts during odontogenesis [57]. Similar to osteopontin, MEPE seems to be a multifunctional ECM protein. Results of in vivo and in vitro studies suggest that MEPE is important for bone mineralization, Pi homeostasis and cell attachment [58, 59, 60]. The protein was originally identified as interacting with PHEX. PHEX by binding to MEPE protects the protein from proteolytic cleavage by cathepsin B. Cleavage by cathepsin B leads to the release of the ASRAM peptide. The ASRAM motif is a functional domain of MEPE responsible for its inhibitory activity [61]. The peptide may be responsible for phosphate and calcium regulation during the mineralization process. ASARM peptide inhibits hydroxyapatite mineralization by binding free calcium with high avidity, and their inhibitory effect is highly dependent on serine residues phosphorylation. AC100, another MEPE fragment, containing the integrin binding (RGD) and glycosaminoglycan-attachment (SGDG) motifs stimulates new bone formation in vitro and in vivo [62].

3.1.4 Dentin matrix protein-1

Dentin matrix protein-1 (DMP1) was the first molecule identified by cloning from the dentin matrix. Besides dentin, the protein is located also in bone and cementum as well as in other nonmineralized tissues [63, 64, 65]. It is remarkably acidic and is a hydrophilic protein with many serine, aspartate, and glutamate residues. The protein is characterized by disordered structure that can aggregate in the presence of calcium ions [66].

It was shown that DMP1 is essential for both odontoblasts and osteoblasts maturation. The protein controls odontogenesis, osteogenesis, and Pi homeostasis. The effect of DMP1 on HA biomineralization depends on posttranslational modifications. It was shown that phosphorylated DMP1 inhibits HA formation and growth, while the dephosphorylated form acts as a HA nucleator [67, 68].

It was demonstrated that DMP1 is proteolytically processed into N-terminal 37-K fragment and 57-K fragment from the C-terminal region, and it is likely that full-length DMP1 is a precursor to these functional fragments [69]. It seems that the 57-K fragment plays a key role in the biomineralization process. The 57-K fragment contains 41 phosphate groups, while the 37-K fragment has only 12 phosphate groups. In addition, the 57-K fragment contains many functional sequences and domains such as the RGD motif [70], the ASARM peptide [71], and the peptide functioning as nucleator [72, 73]. In contrast to the full-length DMP1, the 57-K fragment promoted HA nucleation and growth [66]. Furthermore, it was shown that DMP1 N-terminal fragment is able to stabilize the metastable amorphous calcium phosphate. Due to high aspartic acid residual content, the 37-K fragment can bind calcium ions very strongly favoring formation and stabilization of the amorphous nuclei [72]. It was shown that the DMP1 57-K fragment also controls calcium carbonate mineralization in vitro [74].

3.1.5 Dentin sialophosphoprotein

Dentin sialophosphoprotein (DSPP) was discovered by cDNA cloning using a mouse odontoblast cDNA library and was the first believed to be connected only with dentin. Subsequent studies have revealed that the protein is expressed also in bone, cementum, and some nonmineralized tissues [75, 76]. Analysis of DSPP knockout mice and mutation in the DSPP gene indicated a special role of protein in dentin mineralization. In humans, a mutation in the DSPP gene causes dentin hypomineralization and significant tooth decay, named dentinogenesis imperfecta [77]. Additionally, studies of DSPP-null mice suggest that DSPP is crucial in the initial mineralization of bone as well as in the remodeling of the skeleton and therefore on bone turnover [78].

It is suggested that DSPP is a precursor protein activated after proteolytic processing. Cleavage of DSPP by zinc metalloproteinase bone morphogenetic protein-1 (BPM1) results in two protein fragments: dentin phosphoprotein (phosphophoryn) (DPP) and dentin sialoprotein (DSP) [79]. Subsequently, cleavage of C-terminal of DSP by matrix metalloproteinase 2 (MMP2) and MMP20 leads to the release of the third fragment called dentin glycoprotein (DGP), which has a strong affinity to hydroxyapatite [80].

Highly acidic DPP is the most abundant NCP of ECM in dentin. Amino acid sequence of DPP is composed mainly of aspartic acid and serine residues, whereas ~80% of serine residues are phosphorylated and phosphorylation is crucial to its function. The protein is also glycosylated [81] and contains ASARM peptide. Due to its amino acid composition and phosphorylation, DPP binds large amounts of calcium ions with high affinity. The protein is involved in nucleation and control of the formation and growth of HA crystals during dentin mineralization [82, 83]. DPP binds to collagen fibrils and is present in front of dentin mineralization [84, 85]. There is a hypothesis that in front of mineralization, DPP is promoting the formation of initial apatite crystals [86]. When predentin is converted to dentin, DPP with other proteins binds to the growing HA faces and inhibits or slows down crystal growth [86, 87, 88].


4. Other proteins specific to teeth or bones

4.1 Tooth

Dentin, enamel, and cementum are calcified tissues and are major components of teeth. Dentin is usually covered by enamel on the crown and cementum on the root and surrounds the entire pulp. About 70% (wt) of dentin consists of the mineral phase, 20% (wt) is an organic material, and 10% (wt) is water. Enamel is the hardest substance in the human body and contains 96% (wt) of mineral phase. Enamel and dentin are created by two layers, namely odontoblasts and ameloblasts. Dentin is characterized by a high content of collagen I comprising ~90% of the dentin organic matrix [89].

4.1.1 Enamel

The organic part of enamel consists mainly of hydrophobic proteins, known as amelogenins and anionic proteins, which include ameloblastin, enamelin, and tuftelin [90]. Enamel also contains sialophosphoproteins and enamel proteases such as matrix-20 metalloproteinase (MMP-20, matrix metalloproteinase-20, also known as enamelysin) and kallikrein 4 (KLK4). At the end of the crystallization, enamel loses almost entire organic matrix, which is degraded and replaced by hydroxyapatite crystals [90]. Residues, small peptides, and amino acids account for only 1% of enamel and do not resemble the original matrix [90].

Amelogenins are a group of heterogeneous proteins present in odontoblasts and identified in enamel of maturing teeth. They are the main proteins of the organic enamel matrix, constituting over 90% of the pool of proteins secreted by ameloblasts into the intercellular matrix during the formation of enamel. These are hydrophobic proteins rich in proline, glutamine, leucine, and histidine. Amelogenins isolated from various organisms are characterized by high homology [91]. Amelogenins belong to IDP groups; conformational analysis by CD and NMR spectroscopy showed that recombinant porcine amelogenin rP172 exists in an extended, unfolded state in the monomeric form [92]. The extended, labile conformation of rP172 amelogenin is compatible with known functions of amelogenin in enamel biomineralization, i.e., self-assembly, associations with other enamel matrix proteins and with calcium phosphate biominerals, and interaction with cell receptors [92].

Amelogenin controls the organization and growth of enamel crystals, and its presence is critical for normal enamel formation. Defects in amelogenin sequence lead to defective enamel crystal formation and organization [93].

Ameloblastin, also known as amelin, is a tooth-specific glycoprotein. Unlike amelogenin, ameloblastin is located close to the cell surface [94]. Ameloblastin accounts for about 5–10% of all proteins present in the enamel, and it is the second most abundant protein among the intercellular matrix of the enamel [95]. Ameloblastin is also synthesized in dentin and cement, but its role in these tissues is not determined. Ameloblastin is a molecule of cell adhesion required to maintain a diversified state of ameloblasts [96]. Bioinformatic analyzes and molecular modeling of the protein structure suggest that it may belong to IDPs [97], which was confirmed by the CD spectra of recombinant mouse protein [98].

The N-terminal fragment of ameloblastin comprising the self-assembly motif was shown to colocalize with amelogenin across the entire growing enamel, indicating the role of the two proteins in the organization of the linear growth of HA crystallites [99, 100, 101]. Both proteins self-assemble into higher order structures from monomeric subunits, similar to type I collagen, the predominant matrix protein of bones, and dentin [102, 103]. Full-length amelogenin undergoes hierarchical stepwise assembly, first forming oligomers, which in turn assemble into higher order structures and stabilize mineral prenucleation clusters, and organize them into parallel arrays of linear chains, yielding the formation of crystallite bundles [102]. There is a hypothesis that the higher order structures of the self-assembled ameloblastin (or most likely its N-terminal moiety) contribute to the oriented growth of the linear chains of amelogenin in the 3D space [104].

4.1.2 Dentin

Dentin forms a support for hard tissues of a tooth. It covers both crown and root structures and is responsible for its shape. The formation of dentin is closely related to bone. Both bone and dentin are composed of a collagenous matrix and a mineral phase with hydroxyapatite plate-like crystals. Mineralization of dentin and bone extracellular matrix is initiated with the aid of matrix vesicles and later involves secretion of families of a specialized matrix protein [105]. In contrast to bones, dentin is not remodeled and does not participate in the regulation of calcium and phosphate metabolism. The tooth formation takes place throughout the lifetime of a tooth. Unlike enamel, dentin mineral content increases with age due to continuous mineral deposition either as physiological secondary dentin or as tertiary dentin following injury [105].

Dentin is composed of a collagen I, which accounts for about 92% of organic components. In addition to collagen, there is also a group of noncollagen proteins, which include dentin-specific phosphoryls (DPPs) and dentin sialoproteins (DSP), sialic acid, osteopontin, dentin matrix proteins (DMP1, DMP2, DMP3), BSP, acidic bone-75 glycoprotein, osteonectin, and proteins rich in γ-carboxyglutamic acid. Among organic components should also be mentioned proteoglycans, growth factors, phospholipids, and enzymes [106, 107]. Inorganic dentin components make up to about 70% of the tissue mass, making the dentin harder than the bone. The mass of a single hydroxyapatite crystal is about 10 times greater than in bone, but many times less than in enamel, and its size is about 35 × 10 × 100 nm [108].

4.1.3 Cementum

Cementum protects the dental root dentin with a very thin layer. In many respects, it is very unique: it is not vascularized and is not innervated, it does not undergo constant remodeling like a bone, but it grows all the time. Cellular and acellular cement are distinguished based on the presence of cementocytes in its structure. The structure and composition of cement resembles bone tissue. Inorganic constituents make up to about 65% of tissue mass and consist mainly of hydroxyapatite crystals [109, 110].

Cementum provides contact between roots of the teeth and periodontium ligaments [111]. hrCEMP1 (recombinant human cementum protein 1) is an isolated form of cementum human β-sheet protein. It has been showed that hrCEMP1 forms clusters of 6.5 nm diameter [111]. hrCEMP1 is an inducer of specific biomineralization proteins. It stimulates the differentiation of osteoblasts and cementoblasts. It is suggested that hrCEMP1 plays a significant role in octacalcium phosphate biomineralization and helps its binding to hydroxyapatite even without posttranslational modifications. X-ray diffraction measurements showed that hrCEMP1 is an inducer of polymorphic crystals [111].

4.2 Bone

The matrix of bone consists of type I collagen molecule self-assembled into a triple helix consisting of two α1 and one α2 chains (ca. 300 nm in length and 1.5 nm in diameter) and hydroxyapatite (Ca10(PO4)6(OH)2) nanocrystals (plate-shaped, 1.5–4 nm in thickness) deposited along collagen fibrils [112, 113]. The collagen fiber does not undergo spontaneous mineralization in the presence of phosphate and calcium ions [20], and the involvement of noncollagen proteins is necessary. The majority of these proteins belong to the SIBLING family described above [27].

Bones and dentin are characterized by a similar composition and the mechanism of their formation [112]. Their organic matrix consists of type I collagen and the mineral matrix built of hydroxyapatite. Osteoblasts and odontoblasts, cells involved in osteogenesis and dentinogenesis, first secrete a nonmineralized matrix—a bone osteoid, and in case of dentin—predentin and then with fibers of collagen I form matrix for biomineralization [112]. Calcium and phosphate ions are dislocated from the vascular network into the mineralization matrix. Osteoid and predentin contain numerous noncollagenous proteins called NCPs. On the basis of mutation experiments and suppression of NCP genes, it is suggested that they stimulate the nucleation and growth of hydroxyapatite crystals [112].

Bones and dentin differ significantly. Bone is a dynamic tissue because it is constantly remodeled, while dentin is a rather static tissue [112]. Osteoblasts produce matrix components as a result of controlling growth factors to form a bone. Hydroxyapatite crystals grow above vesicles, thus creating mineralization centers. Bones have a lot of vessels, and they store calcium ions. The reason for bone resorption is the action of lysosomal enzymes produced by osteoclasts and lowering the pH in extracellular bone matrix.

Osteoclasts are responsible for the attachment, bone degradation, and subsequent tissue resorption. It was found that this is possible due to the strong polarization of osteoclasts. They have both frontal and posterior abdominal polarization. On the underside of the osteoclasts, there are structures responsible for the degradation of the mineral surface. The adhesion zone is located in the sealing zone [114]—a ring made of actin and podosomes in which extracellular resorption pit is segregated and is used to retain heavy substances (minerals) formed during bone resorption near the bone surface [43, 114]. Podosomes are dynamic structures built of actin. They perform important functions, including adhesion, destruction of the bone and its matrix, and recognition of the appropriate medium [115]. Podosomes contain a large number of V-ATPase molecules that pump protons and secrete proteases, which promote bone degradation [114].



This work was supported by the National Science Center (Poland) [UMO-2015/19/B/ST10/02148] and in a part by statutory activity subsidy from the Polish Ministry of Science and High Education for the Faculty of Chemistry of Wroclaw University of Science and Technology.


Conflict of interest

Authors declare no conflict of interest.


  1. 1. Lowenstam HA, Weiner S. On Biomineralization. New York: Oxford University Press; 1989. 324 p
  2. 2. Dorozhkin SV. Calcium orthophosphates occurrence, properties, biomineralization, pathological calcification and biomimetic applications. Biomatter. 2011;1:121-164
  3. 3. Dorozhkin SV. Calcium orthophosphates (CaPO4): Occurrence and properties. Progress in Biomaterials. 2016;5:9-70
  4. 4. Grynpas MD, Omelon S. Transient precursor strategy or very small biological apatite crystals? Bone. 2007;4:162-164
  5. 5. Young RA. Biological apatite vs hydroxyapatite at the atomic level. Clinical Orthopaedics and Related Research. 1975;113:249-262
  6. 6. Wopenka B, Pasteris JD. A mineralogical perspective on the apatite in bone. Materials Science and Engineering. 2005;C 25:131-143
  7. 7. Hołubowicz R, Porębska A, Poznar M, Różycka M, Dobryszycki P. Biomineralization-precision of shape, structure and properties controlled by proteins. Postepy Biochemii. 2015;61:364-380
  8. 8. Marin F, Luquet G. Unusually acidic proteins in biomineralization. In: Handbook of Biomineralization: Biological Aspects and Structure Formation. USA: Wiley; 2008. DOI: 10.1002/9783527619443.ch16
  9. 9. Gorski JP. Acidic phosphoproteins from bone matrix: A structural rationalization of their role in biomineralization. Calcified Tissue International. 1992;50:391-396
  10. 10. Jain A, Karadag A, Fohr B, Fisher LW, Fedarko NS. Three SIBLINGs (small integrin-binding ligand, N-linked glycoproteins) enhance factor H’s cofactor activity enabling MCP-like cellular evasion of complement-mediated attack. The Journal of Biological Chemistry. 2002;277:13700-13708
  11. 11. Wojtas M, Dobryszycki P, Ożyhar A. Intrinsically disordered proteins in biomineralization. In: Advanced Topics in Biomineralization. UK: IntechOpen; 2012. pp. 3-32. DOI: 10.5772/31121
  12. 12. Uversky VN, Gillespie JR, Fink AL. Why are “natively unfolded” proteins unstructured under physiologic conditions? Proteins. 2000;41:415-427
  13. 13. Romero P, Obradovic Z, Li X, Garner EC, Brown CJ, Dunker AK. Sequence complexity of disordered protein. Proteins. 2001;42:38-48
  14. 14. Ravindran S, George A. Multifunctional ECM proteins in bone and teeth. Experimental Cell Research. 2014;325(2):148-154
  15. 15. Alberts B, Johnson A, Lewis J, et al. Molecular biology of the cell. In: The Extracellular Matrix of Animals. Available from: 4th ed. New York: Garland Science; 2002
  16. 16. Brodsky B, Persikov AV. Molecular structure of the collagen triple helix. Advances in Protein Chemistry. 2005;70:301-339
  17. 17. Van der Rest M, Garrone R. Collagen family of proteins. The FASEB Journal. 1991;13:2814-2823
  18. 18. Olszta MJ, Cheng X, Jee SS, Kumar R, Kim Y, Kaufman MJ, et al. Bone structure and formation, a new perspective. Materials Science and Engineering R. 2007;58:77-116
  19. 19. Knott L, Bailey AJ. Collagen cross-links in mineralizing tissues, a review of their chemistry, function, and clinical relevance. Bone. 1998;22:181-187
  20. 20. Nudelman F, Lausch AJ, Sommerdijk NA, Sone ED. In vitro models of collagen biomineralization. Journal of Structural Biology. 2013;183:258-269
  21. 21. Boskey AL. Biomineralization: An overview. Connective Tissue Research. 2003;44:5-9
  22. 22. Wright PE, Dyson HJ. Intrinsically unstructured proteins, re-assessing the protein structure-function paradigm. Journal of Molecular Biology. 1999;293:321-331
  23. 23. Tompa P. Intrinsically unstructured proteins. Trends in Biochemical Sciences. 2002;27:527-533
  24. 24. Iakoucheva LM, Radivojac P, Brown CJ, O’Connor TR, Sikes JG, Obradovic Z, et al. The importance of intrinsic disorder for protein phosphorylation. Nucleic Acids Research. 2004;32:1037-1049
  25. 25. Kalmar L, Homola D, Varga D, Tompa P. Structural disorder in proteins brings order to crystal growth in biomineralization. Bone. 2012;51:528-534
  26. 26. Boskey AL, Villarreal-Ramirez E. Intrinsically disordered proteins and biomineralization. Matrix Biology. 2016;52-54:43-59
  27. 27. Staines KA, MacRae VE, Farquharson C. The importance of the SIBLING family of proteins on skeletal mineralisation and bone remodelling. Journal of Endocrinology. 2012;214:241-255
  28. 28. Fisher LW, Torchia DA, Fohr B, Young MF, Fedarko NS. Flexible structures of SIBLING proteins, bone sialoprotein, and osteopontin. Biochemical and Biophysical Research Communications. 2001;280:460-465
  29. 29. Rowe PS, Kumagai Y, Gutierrez G, Garrett IR, Blacher R, Rosen D, et al. MEPE has the properties of an osteoblastic phosphatonin and minhibin. Bone. 2004;34:303-319
  30. 30. David V, Martin AC, Hedge AM, Drezner MK, Rowe PS. ASARM peptides: PHEX-dependent, independent regulation of serum phosphate. American Journal of Physiology. Renal Physiology. 2010;300:F783-F791
  31. 31. Qin C, Baba O, Butler WT. Post-translational modification of SIBLING proteins and their roles in osteogenesis and dentinogenesis. Critical Reviews in Oral Biology and Medicine. 2004;15:126-136
  32. 32. Icer MA, Gezmen-Karadag M. The multiple functions and mechanisms of osteopontin. Clinical Biochemistry. 2018;59:17-24
  33. 33. Noda M, Vogel RL, Craig AM, Prahl J, DeLuca HF, Denhardt DT. Identification of a DNA sequence responsible for binding of the 1,25-dihydroxyvitamin D3 receptor and 1,25-dihydroxyvitamin D3 enhancement of mouse secreted phosphoprotein 1 (SPP-1 or osteopontin) gene expression. Proceedings of the National Academy of Sciences of the United States of America. 1990;87:9995-9999
  34. 34. Reinholt FP, Hultenby K, Oldberg A, Heinegård D. Osteopontin—A possible anchor of osteoclasts to bone. Proceedings of the National Academy of Sciences. 1990;87:4473-4475
  35. 35. Sodek J, Ganss B, McKee MD. Osteopontin. Critical Reviews in Oral Biology and Medicine. 2000;11:279-303
  36. 36. Giachelli CM, Steitz S. Osteopontin: A versatile regulator of inflammation and biomineralization. Matrix Biology. 2000;19:615-622
  37. 37. McKee M, Nanci A. Osteopontin at mineralized tissue interfaces in bone, teeth, and osseointegrated implants: Ultrastructural distribution and implications for mineralized tissue formation, turnover, and repair. Microscopy Research and Technique. 1996;33:141-164
  38. 38. Chellaiah M, Hruska K. The integrin αVβ3 and CD44 regulate the actions of osteopontin on osteoclast motility. Calcified Tissue International. 2002;72:97-205
  39. 39. Boskey AL, Maresca M, Ullrich W, Doty SB, Butler WT, Prince CW. Osteopontin-hydroxyapatite interactions in vitro: Inhibition of hydroxyapatite formation and growth in a gelatin-gel. Bone and Mineral. 1993;22:147-159
  40. 40. Hunter GK. Role of osteopontin in modulation of hydroxyapatite formation. Calcified Tissue International. 2013;93:348-354
  41. 41. Boskey AL, Spevak L, Paschalis E, Doty SB, McKee MD. Osteopontin deficiency increases mineral content and mineral crystallinity in mouse bone. Calcified Tissue International. 2002;71:145-154
  42. 42. Addison WN, Masica DL, Gray JJ, McKee MD. Phosphorylation-dependent inhibition of mineralization by osteopontin ASARM peptides is regulated by PHEX cleavage. Journal of Bone and Mineral Research. 2010;25:695-705
  43. 43. Boskey AL, Christensen B, Taleb H, Sorensen ES. Post-translational modification of osteopontin: Effects on in vitro hydroxyapatite formation and growth. Biochemical and Biophysical Research Communications. 2012;419:333-338
  44. 44. Bianco P, Fisher LW, Young MF, Termine JD, Robey PG. Expression of bone sialoprotein (BSP) in developing human tissues. Calcified Tissue International. 1991;49:421-426
  45. 45. Tye CE, Rattray KR, Warner KJ, Gordon JA, Sodek J, Hunter GK, et al. Delineation of the hydroxyapatite-nucleating domains of bone sialoprotein. The Journal of Biological Chemistry. 2003;278:7949-7955
  46. 46. Tye CE, Hunter GK, Goldberg HA. Identification of the type I collagen-binding domain of bone sialoprotein and characterization of the mechanism of interaction. The Journal of Biological Chemistry. 2005;280:13487-13492
  47. 47. Wuttke M, Muller S, Nitsche DP, Paulsson M, Hanisch FG, Maurer P. Structural characterization of human recombinant and bone-derived bone sialoprotein. Functional implications for cell attachment and hydroxyapatite binding. The Journal of Biological Chemistry. 2001;276:36839-36848
  48. 48. Ganss B, Kim RH, Sodek J. Bone sialoprotein. Critical Reviews in Oral Biology and Medicine. 1999;10:79-98
  49. 49. Malaval L, Wade-Gueye NM, Boudiffa M, Fei J, Zirngibl R, et al. Bonesialoprotein plays a functional role in bone formation and osteoclastogenesis. The Journal of Experimental Medicine. 2008;205:1145-1153
  50. 50. Bouleftour W, Boudiffa M, Wade-Gueye NM, Bouët G, Cardelli M, Laroche N, et al. Skeletal development of mice lacking bone sialoprotein (BSP)—Impairment of long bone growth and progressive establishment of high trabecular bone mass. PLoS One. 2014;9:e95144
  51. 51. Valverde P, Zhang J, Fix A, Zhu J, Ma W, Tu Q , et al. Overexpression of bone sialoprotein leads to an uncoupling of bone formation and bone resorption in mice. Journal of Bone and Mineral Research. 2008;23:1775-1788
  52. 52. Hunter GK, Goldberg HA. Nucleation of hydroxyapatite by bone sialoprotein. Proceedings of the National Academy of Sciences. 1993;90:8562-8565
  53. 53. Baht GS, Hunter GK, Goldberg HA. Bone sialoprotein-collagen interactionpromotes hydroxyapatite nucleation. Matrix Biology. 2008;27:600-608
  54. 54. George A, Veis A. Phosphorylated proteins and control over apatite nucleation, crystal growth, and inhibition. Chemical Reviews. 2008;108:4670-4693
  55. 55. Baht GS, O’Young J, Borovina A, Chen H, Tye CE, Karttunen M, et al. Phosphorylation of Ser136 is critical for potent bone sialoprotein-mediated nucleation of hydroxyapatite crystals. The Biochemical Journal. 2010;428:385-395
  56. 56. Foster BL, Ao M, Willoughby C, Soenjaya Y, Holm E, Lukashova L, et al. Mineralization defects in cementum and craniofacial bone from loss of bone sialoprotein. Bone. 2015;78:150-164
  57. 57. Nampei A, Hashimoto J, Hayashida K, Tsuboi H, Shi K, Tsuji I, et al. Matrix extracellular phosphoglycoprotein (MEPE) is highly expressed in osteocytes in human bone. Journal of Bone and Mineral Metabolism. 2004;22:176-184
  58. 58. Gowen LC, Petersen DN, Mansolf AL, Qi H, Stock JL, et al. Targeted disruption of the osteoblast/osteocyte factor 45 gene (OF45) results in increased bone formation and bone mass. Journal of Biological Chemistry. 2003;278:1998-2007
  59. 59. Quarles LD. FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization. American Journal of Physiology. Endocrinology and Metabolism. 2003;285:1-9
  60. 60. Dobbie H, Unwin RJ, Faria NJ, Shirley DG. Matrix extracellular phosphoglycoprotein causes phosphaturia in rats by inhibiting tubular phosphate reabsorption. Nephrology, Dialysis, Transplantation. 2008;23:730-733
  61. 61. Addison WN, Nakano Y, Loisel T, Crine P, McKee MD. MEPE-ASARM peptides control extracellular matrix mineralization by binding to hydroxyapatite: An inhibition regulated by PHEX cleavage of ASARM. Journal of Bone and Mineral Research. 2008;23:1638-1649
  62. 62. Hayashibara T, Hiraga T, Yi B, Nomizu M, Kumagai Y, Nishimura R, et al. A synthetic peptide fragment of human MEPE stimulates new bone formation in vitro and in vivo. Journal of Bone and Mineral Research. 2004;19:455-462
  63. 63. George A, Sabsay B, Simonian PA, Veis A. Characterization of a novel dentin matrix acidic phosphoprotein, implications for induction of biomineralization. Journal of Biological Chemistry. 1993;268:12624-12630
  64. 64. MacDougall M, Gu TT, Luan X, Simmons D, Chen J. Identification of a novel isoform of mouse dentin matrix protein 1: Spatial expression in mineralized tissues. Journal of Bone and Mineral Research. 1998;13:422-431
  65. 65. Sun Y, Chen L, Ma S, Zhou J, Zhang H, Feng JQ , et al. Roles of DMP1 processing in osteogenesis, dentinogenesis and chondrogenesis. Cells, Tissues, Organs. 2011;194:199-204
  66. 66. Gericke A, Qin C, Sun Y, Redfern R, Redfern D, Fujimoto Y, et al. Different forms of DMP1 play distinct roles in mineralization. Journal of Dental Research. 2010;89:355-359
  67. 67. He G, Dahl T, Veis A, George A. Dentin matrix protein 1 initiates hydroxyapatite formation in vitro. Connective Tissue Research. 2003;44:240-245
  68. 68. Tartaix PH, Doulaverakis M, George A, Fisher LW, Butler WT, Qin C, et al. In vitro effects of dentin matrix protein-1 on hydroxyapatite formation provide insights into in vivo functions. Journal of Biological Chemistry. 2004;279:18115-18120
  69. 69. Qin C, Brunn JC, Cook RG, Orkiszewski RS, Malone JP, Veis A, et al. Evidence for the proteolytic processing of dentin matrix protein 1. Identification and characterization of processed fragments and cleavage sites. Journal of Biological Chemistry. 2003;278:34700-34708
  70. 70. Kulkarni GV, Chen B, Malone JP, Sampath Narayanan A, George A. Promotion of selective cell attachment by the RGD sequence in dentine matrix protein 1. Archives of Oral Biology. 2000;45:475-484
  71. 71. Rowe PS. The wrickkened pathways of FGF23, MEPE and PHEX. Critical Reviews in Oral Biology and Medicine. 2004;15:264-281
  72. 72. Gajjeraman S, Narayanan K, Hao J, Qin C, George A. Matrix macromolecules in hard tissues control the nucleation and hierarchical assembly of hydroxyapatite. The Journal of Biological Chemistry. 2007;282:1193-1204
  73. 73. Lu Y, Qin C, Xie Y, Bonewald LF, Feng JQ. Studies of the DMP1 57-kDa functional domain both in vivo and in vitro. Cells, Tissues, Organs. 2008;189:175-185
  74. 74. Porębska A, Ożyhar A, Dobryszycki P. Intrinsically disordered recombinant 57K fragment of human DMP1 influences the in vitro crystallization of CaCO3. Protein Science. 2015;24(Suppl 1):137-138. DOI: 10.1002/pro.2823
  75. 75. Qin C, Brunn JC, Cadena E, Ridall A, Tsujigiwa H, Nagatsuka H, et al. The expression of dentin sialophosphoprotein gene in bone. Journal of Dental Research. 2002;81:392-394
  76. 76. Baba O, Qin C, Brunn JC, Jones JE, Wygant JN, BW MI, et al. Detection of dentin sialoprotein in rat periodontium. European Journal of Oral Sciences. 2004;112:163-170
  77. 77. Kim JW, Hu JCC, Lee JI, et al. Mutational hot spot in the DSPP gene causing dentinogenesis imperfecta type II. Human Genetics. 2005;116:186-191
  78. 78. Verdelis K, Ling Y, Sreenath T, Haruyama N, MacDougall M, Van der Meulen MC, et al. DSPP effects on in vivo bone mineralization. Bone. 2008;43:983-990
  79. 79. Yamakoshi Y, Simmer JP. Structural features, processing mechanism and gene splice variants of dentin sialophosphoprotein. Japanese Dental Science Review. 2018;54:183-196
  80. 80. Yamakoshi Y, Hu JC, Fukae M, Zhang H, Simmer JP. Dentin glycoprotein: The protein in the middle of the dentin sialophosphoprotein chimera. The Journal of Biological Chemistry. 2005;280:17472-17479
  81. 81. Yamakoshi Y, Lu Y, Hu JC, Kim JW, Iwata T, Kobayashi K, et al. Porcine dentin sialophosphoprotein: Length polymorphisms, glycosylation, phosphorylation, and stability. The Journal of Biological Chemistry. 2008;283:14835-14844
  82. 82. He G, Ramachandran A, Dahl T, George S, Schultz D, Cookson D, et al. Phosphorylation of phosphophoryn is crucial for its function as a mediator of biomineralization. The Journal of Biological Chemistry. 2005;280:33109-33114
  83. 83. Boskey AL, Maresca M, Doty S, Sabsay B, Veis A. Concentration dependent effects of dentin phosphophoryn in the regulation of in vitro hydroxyapatite formation and growth. Bone and Mineral. 1990;11:55-65
  84. 84. Stetler-Stevenson WG, Veis A. Type I collagen shows a specific binding affinity for bovine dentin phosphophoryn. Calcified Tissue International. 1986;38:135-141
  85. 85. Traub W, Jodaikin A, Arad T, Veis A, Sabsay B. Dentin phosphophoryn binding to collagen fibrils. Matrix. 1992;12:197-201
  86. 86. Prasad M, Butler WT, Qin C. Dentin sialophosphoprotein in biomineralization. Connective Tissue Research. 2010;51:404-417
  87. 87. Butler WT. Dentin matrix proteins. European Journal of Oral Sciences. 1998;106(Suppl 1):204-210
  88. 88. Butler WT, Brunn JC, Qin C. Dentin extracellular matrix (ECM) proteins: Comparison to bone ECM and contribution to dynamics of dentinogenesis. Connective Tissue Research. 2003;44(Suppl 1):171-178
  89. 89. Goldberg M, Kulkarni AB, Young M, Boskey A. Dentin: Structure, composition and mineralization. The role of dentin ECM in dentin formation and mineralization. Frontiers in Bioscience. 2011;3:711-735
  90. 90. Moradian-Oldak J. Protein-mediated enamel mineralization. Frontiers in bioscience (Landmark edition). 2012;17:1996-2023
  91. 91. Ye L, Le TQ , Zhu L, Butcher K, Schneider RA, Li W, et al. Amelogenins in human developing and mature dental pulp. Journal of Dental Research. 2006;85:814-818
  92. 92. Delak K, Harcup C, Lakshminarayanan R, Sun Z, Fan YJ, Moradian-Oldak J, et al. The tooth enamel protein, porcine amelogenin, is an intrinsically disordered protein with an extended molecular configuration in the monomeric form. Biochemistry. 2009;48:2272-2281
  93. 93. Paine ML, Luo W, Zhu DH, Bringas PJ, Snead ML. Functional domains for amelogenin revealed by compound genetic defects. Journal of Bone and Mineral Research. 2003;18:466-472
  94. 94. Nanci A, Zalzal S, Lavoie P, Kunikata M, Chen W, Krebsbach PH, et al. Comparative immunochemical analyses of the developmental expression and distribution of ameloblastin and amelogenin in rat incisors. The Journal of Histochemistry and Cytochemistry. 1998;46:911-934
  95. 95. Krebsbach PH, Lee SK, Matsuki Y, Kozak CA, Yamada KM, Yamada Y. Full length sequence, localization, and chromosomal mapping of ameloblastin: A novel tooth-specific gene. The Journal of Biological Chemistry. 1996;271:4431-4435
  96. 96. Fukumoto S, Kiba T, Hall B, Iehara N, Nakamura T, Longenecker G, et al. Ameloblastin is a cell adhesion molecule required for maintaining the differentiation state of ameloblasts. The Journal of Cell Biology. 2004;167:973-983
  97. 97. Vymetal J, Slaby I, Spahr A, Vondrasek J, Lyngstadaas SP. Bioinformatic analysis and molecular modelling of human ameloblastin suggest a two-domain intrinsically unstructured calcium-binding protein. European Journal of Oral Sciences. 2008;116:124-134
  98. 98. Mazumder P, Prajapati S, Lokappa SB, Gallon V, Moradian-Oldak J. Analysis of co-assembly and co-localization of ameloblastin and amelogenin. Frontiers in Physiology. 2014;5:274
  99. 99. Mazumder P, Prajapati S, Bapat R, Moradian-Oldak J. Amelogenin ameloblastin spatial interaction around maturing enamel rods. Journal of Dental Research. 2016;95(9):1042-1048
  100. 100. Uchida T, Tanabe T, Fukae M, Shimizu M, Yamada M, Miake K, et al. Immunochemical and immunohistochemical studies, using antisera against porcine 25 kDa amelogenin, 89 kDa enamelin and the 13-17 kDa nonamelogenins, on immature enamel of the pig and rat. Histochemistry. 1991;96:129-138
  101. 101. Uchida T, Murakami C, Dohi N, Wakida K, Satoda T, Takahashi O. Synthesis, secretion, degradation, and fate of ameloblastin during the matrix formation stage of the rat incisor as shown by immunocytochemistry and immunochemistry using region-specific antibodies. The Journal of Histochemistry and Cytochemistry. 1997;45:1329-1340
  102. 102. Fang PA, Conway JF, Margolis HC, Simmer JP, Beniash E. Hierarchical self assembly of amelogenin and the regulation of biomineralization at the nanoscale. Proceedings of the National Academy of Sciences of the United States of America. 2011;108:14097-14102
  103. 103. Wald T et al. Intrinsically disordered enamel matrix protein ameloblastin forms ribbon-like supramolecular structures via an N-terminal segment encoded by exon 5. The Journal of Biological Chemistry. 2013;288:22333-22345
  104. 104. Wald T, Spoutil F, Osickova A, Prochazkova M, Benada O, Kasparek P, et al. Intrinsically disordered proteins drive enamel formation via an evolutionarily conserved self-assembly motif. Proceedings of the National Academy of Sciences. 2017;114:E1641-E1650
  105. 105. MacDougall MJ, Javed A. Dentin and bone: Similar collagenous mineralized tissues. In: Bronner F, Farach-Carson M, Roach H, editors. Bone and Development. Topics in Bone Biology. Vol. 6. London: Springer; 2010
  106. 106. Orsini G, Ruggeri A, Mazzoni A, Nato F, Manzoli L, Putignano A, et al. A review of the nature, role, and function of dentin non-collagenous proteins. Part 1: Proteoglycans and glycoproteins. Endodontic Topics. 2009;21:1-18
  107. 107. Niu LN, Zhang W, Pashley DH, Breschi L, Mao J, Chen JH, et al. Biomimetic remineralization of dentin. Dental Materials. 2014;30:77-96
  108. 108. Kinney JH, Marshall SJ, Marshall GW. The mechanical properties of human dentin: A critical review and re-evaluation of the dental literature. Critical Reviews in Oral Biology and Medicine. 2003;14:13-29
  109. 109. Bosshardt DD, Selvig KA. Dental cementum: The dynamic tissue covering of the root. Periodontology 2000. 2000;1997(13):41-75
  110. 110. Saygin NE, Giannobile WV, Somerman MJ. Molecular and cell biology of cementum. Periodontology 2000. 2000;2000(24):73-98
  111. 111. Villarreal-Ramírez E, Moreno A, Mas-Oliva J, Chávez-Pacheco LJ, Narayanan AS, Gil-Chavarría I, et al. Characterization of recombinant human cementum protein 1 (hrCEMP1): Primary role in biomineralization. Biochemical and Biophysical Research Communications. 2009;384:49-54
  112. 112. Stock SR. The mineral–collagen interface in bone. Calcified Tissue International. 2015;97:262-280
  113. 113. Weiner S, Wagner HD. The material bone: Structure-mechanical function relations. Annual Review of Materials Science. 1998;28:271-298
  114. 114. Akisaka T, Yoshida A. Ultrastructural analysis of apatite-degrading capability of extended invasive podosomes in resorbing osteoclasts. Micron. 2016;88:37-47
  115. 115. Veillat V, Spuul P, Daubon T, Egaña I, Kramer I, Génot E. Podosomes: Multipurpose organelles? The International Journal of Biochemistry & Cell Biology. 2015;65:52-60

Written By

Marta Kalka, Anna Zoglowek, Andrzej Ożyhar and Piotr Dobryczycki

Submitted: 17 January 2019 Reviewed: 07 May 2019 Published: 06 June 2019